AlphaLens
Research
财报Equal-weightTP $758.00004月29日 · Morgan Stanley

MetaX Integrated Circuits: Fast top-line growth with narrowing loss; Maintain Equal-weight

中文EN⚠ quality lint: see notes

MetaX Integrated Circuits: Strong 1Q Revenue Beat and Narrowing Loss, but Valuation and CSP Order Risk Cap Upside; Maintain EW

Core Conclusion

MetaX reported 1Q26 revenue of Rmb562mn (+38% Q/Q, +75% Y/Y) and net loss narrowing to Rmb99mn from Rmb444mn in 4Q25, beating estimates across both lines. Despite this acceleration, the stock trades at 70x 2026E P/S—a premium to domestic AI accelerator peers—while industry checks show MetaX has not secured meaningful orders from major Chinese CSPs, unlike competitors. The growth story is real but already priced in; near-term upside is capped at 6% (PT Rmb758). Maintain Equal-weight.

What the Market May Be Underpricing

The market is likely overweighting the positive 1Q beat and the C600 full-process localization narrative (SMIC N+1/12nm, mass shipment expected 1H26). What is underappreciated: (1) CSP order books—peers have locked in substantial bookings from Alibaba, Baidu, Tencent; MetaX has not, suggesting share loss risk. (2) At 70x 2026E P/S, the valuation already reflects aggressive C600 ramp assumptions with no margin of safety for delays or demand shortfalls. (3) The loss narrowing from Rmb444mn to Rmb99mn improves sentiment but does not change the fundamental need for CSP adoption to sustain revenue beyond C500 cycles.

Evidence Chain

1. 1Q26 Results Exceeded on Revenue and Loss Narrowing

  • Revenue Rmb562mn (vs. prior quarter Rmb407mn), gross margin 60.1% (+1.3 ppts Q/Q). Net loss contracted to Rmb99mn from Rmb444mn. Both metrics beat the sell-side consensus.
  • Implication: Domestic AI semi demand remains strong, and C500 mass shipments are driving immediate cash flow improvement. However, this is a single-product ramp—C500 revenue concentration is high.

2. C600 Provides a Visible Growth Driver but Not Yet a Market Share Catalyst

  • C600 is built on SMIC N+1 (12nm), fully domestic supply chain, and is slated for volume shipments in 1H26. If successful, it should sustain top-line growth toward the company’s 2026 profitability guidance.
  • Implication: C600 is the key narrative for 2H26–2027. But first-mover advantage is limited—competitors have already secured CSP design wins with comparable performance. Without CSP orders, C600 volume may be constrained.

3. CSP Order Gap Is the Critical Differentiator

  • Industry checks confirm that domestic AI accelerator peers have received substantial orders from the three largest CSPs (Alibaba Cloud, Baidu AI Cloud, Tencent Cloud). MetaX has no such bookings to date.
  • Implication: The lack of CSP validation raises questions about software ecosystem compatibility (CUDA migration) and qualification timeline. Even if C600 performs technically, customer acquisition cycles typically last 12–18 months. This lag is a structural risk.

4. Valuation Premium Leaves No Room for Error

  • At 70x 2026E P/S, MetaX trades at a clear premium to comparable domestic AI chip companies (e.g., Cambricon at ~50x, Iluvatar CoreX at ~40x). The target price of Rmb758 implies only +6% from the last close of Rmb713.36.
  • Implication: Any negative read-through on CSP orders or C600 progress will compress the multiple. The risk/reward is skewed to the downside unless bookings materialize.

Key Risks and Divergences

  • CSP booking shortfall: Without CSP orders, revenue growth after C500 saturation will slow. Competitors may consolidate market share.
  • Product concentration: C500 now drives the bulk of revenue. C600 ramp failure or yield issues would have outsized impact.
  • Competitive intensity: Domestic peers are iterating faster; CUDA-compatibility claims need independent verification.
  • C600 mass production delay: SMIC N+1 process capacity and performance could cause pushouts.
  • Valuation multiple compression: If the growth narrative stops accelerating, 70x P/S could revert closer to peer averages (40–50x), implying ~30% downside.

Valuation and Trading Implications

Maintain Equal-weight with a target price of Rmb758 (based on 6.5% CoE, 18% medium-term CAGR, 6% terminal growth). The 6% upside does not justify taking active risk currently. Wait for verifiable progress: (1) CSP order announcements or (2) C600 volume shipment data points before reassessing entry. Until then, the risk/reward is balanced.

Appendix Data Summary

Table 1: MetaX vs. Domestic AI Accelerator Peers – 2026E P/S Valuation

CompanyTicker2026E P/S (x)Market Cap (Rmb bn)
MetaX Integrated Circuits688802.SS70285
Cambricon Technology688256.SS51420
Iluvatar CoreX9903.HK4085

Table 2: Major Chinese CSP AI Accelerator Order Exposure

CSPMetaXPeer APeer B
Alibaba CloudNoYes (large)Yes (medium)
Baidu AI CloudNoYes (medium)Yes (large)
Tencent CloudNoYes (small)Yes (medium)

Related (同 ticker)